Sigmund Rogich - Apr 5, 2022 Form 4 Insider Report for BIOVIE INC. (BIVI)

Role
Director
Signature
/s/ Sig Rogich
Stock symbol
BIVI
Transactions as of
Apr 5, 2022
Transactions value $
$0
Form type
4
Date filed
4/21/2022, 12:47 PM
Next filing
Jan 18, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIVI Stock Option (right to buy) Award $0 +123K $0.00 123K Apr 5, 2022 Common Stock 123K $5.04 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options granted pursuant to the Company's 2019 Omnibus Equity Incentive Plan.
F2 The options were 25% vested upon grant, with the remaining 75% vesting ratably over a three-year period on each anniversary of the grant date.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney